9G4H9, a catalytic antibody displaying β-lactamase-like activity, has been developed by the anti-idiotypic approach using β-lactamase as the first antigen. Thus 9G4H9 represents the 'internal image' of β-lactamase. We selected a cyclic peptide anchored to a bacteriophage M13 library using 9G4H9 as the target. Pep90 is a cyclic heptapeptide enclosed between two cysteine residues. We showed that Pep90 could inhibit both TEM-1 β-lactamase (Ki = 333 μm) and several penicillin-binding proteins (IC50 values ranging from 6-62 μm). We determined that the tryptophan residue of Pep90 is of crucial importance for its inhibitory activity. Using Pep90 as a scaffold, we generated a new class of peptidomimetics that retained inhibitory activity towards TEM-1 β-lactamase. © 2010 The Authors Journal compilation © 2010 FEBS.
CITATION STYLE
Phichith, D., Bun, S., Padiolleau-Lefevre, S., Guellier, A., Banh, S., Galleni, M., … Avalle, B. (2010). Novel peptide inhibiting both TEM-1 β-lactamase and penicillin-binding proteins. FEBS Journal, 277(23), 4965–4972. https://doi.org/10.1111/j.1742-4658.2010.07906.x
Mendeley helps you to discover research relevant for your work.